Publications by authors named "Rahul Bhambri"

Claim this Profile
C
Coexisting Calcific Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Real-World Evaluation of Clinical Characteristics and Outcomes.
Ahmad Masri, Yong Chen, A Carmine Colavecchia, Darrin Benjumea, Aaron Crowley, Rahul Bhambri

J Am Heart Assoc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-enabled tools in cardiovascular medicine: A survey of current use, perceptions, and challenges.
Alexander Schepart, Arianna Burton, Larry Durkin, Allison Fuller, Ellyn Charap, Rahul Bhambri

Cardiovasc Digit Health J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States.
Rahul Bhambri, A Carmine Colavecchia, Marianna Bruno, Yong Chen, Jose Alvir

Am J Cardiovasc Drugs· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies.
Mark H Rozenbaum, Andrea Garcia, Daniel Grima, Diana Tran, Rahul Bhambri

Eur Heart J Qual Care Clin Outcomes· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy.
Mark H Rozenbaum, Diana Tran, Rahul Bhambri, Jose Nativi-Nicolau

Am J Cardiovasc Drugs· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort.
Anuja Roy, Andrew Peterson, Nick Marchant, Jose Alvir, Rahul Bhambri

J Manag Care Spec Pharm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Characteristics and Secondary Medication Adherence Patterns Among Patients Receiving Tafamidis Prescriptions: A Retrospective Analysis Using a National Specialty Pharmacy Dispensing Database.
Anuja Roy, Andrew Peterson, Nick Marchant, Jose Alvir, Rahul Bhambri

Patient Prefer Adherence· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population.
Jamieson M Bourque, Alexander Schepart, Rahul Bhambri, Adam Castaño, Alex O'Brien

Am J Cardiol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy.
Mark H Rozenbaum, Samuel Large, Rahul Bhambri, Michelle Stewart, Robert Young

J Comp Eff Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review.
Mark H Rozenbaum, Samuel Large, Rahul Bhambri, Michelle Stewart, Jo Whelan

Cardiol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative tolerability of treatments for acute migraine: A network meta-analysis.
Kristian Thorlund, Kabirraaj Toor, Ping Wu, Keith Chan, Eric Druyts, Rahul Bhambri

Cephalalgia· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Barrett W Jeffers, Jeffery Robbins, Rahul Bhambri

Am J Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA's Expedited Programs and Their Impact on the Availability of New Therapies.
Nehar Damle, Shilvi Shah, Praneeta Nagraj, Pardis Tabrizi, Gustavo Enrique Rodriguez, Rahul Bhambri

Ther Innov Regul Sci· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of medication overuse headache across classes of treatments for acute migraine.
Kristian Thorlund, Christina Sun-Edelstein, Eric Druyts, Steve Kanters, Shanil Ebrahim, Rahul Bhambri

J Headache Pain· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication.
Barrett W Jeffers, Jeffery Robbins, Rahul Bhambri, Dalia Wajsbrot

Am J Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental Blood Pressure-Lowering Effect of Titrating Amlodipine for the Treatment of Hypertension in Patients Including Those Aged ≥55 Years.
Barrett W Jeffers, Rahul Bhambri, Jeffery Robbins

Am J Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis.
Barrett W Jeffers, Rahul Bhambri, Jeffery Robbins

Vasc Health Risk Manag· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine.
Rahul Bhambri, Jack Mardekian, Larry Z Liu, Edward Schweizer, Elodie Ramos

Int J Gen Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Rahul Bhambri, Vincent T Martin, Younos Abdulsattar, Stephen Silberstein, Mary Almas

Headache· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban (xarelto) for the prevention of thromboembolic disease: an inside look at the oral direct factor xa inhibitor.
Younos Abdulsattar, Rahul Bhambri, Anna Nogid

P T· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis